| 书目名称 | Progress in Drug Research | | 编辑 | Ernst Jucker | | 视频video | | | 概述 | WELL-ESTABLISHED BOOK SERIES CONTAINING REVIEWS.ON A WIDE SPECTRUM OF HIGHLY TOPICAL AREAS IN CURRENT PHARMACEUTICAL AND PHARMACOLOGICAL RESEARCH | | 丛书名称 | Progress in Drug Research | | 图书封面 |  | | 描述 | Hepatitis C virus (HCV) was first identified in 1989 as the etiologic agent of non-A, non-B hepatitis [1] and is currently recognized as the leading cause of chronic liver disease worldwide. In contrast to hepatitis B virus infection, in which only about 5% of adult infections become chronic, more than 80% of HCV-infected patients develop chronic hepatitis. Moreover, 20-50% of those persistently infected with HCV will develop liver cirrhosis and hepatocellu lar carcinoma (HCC) [2]. It is estimated that there are 10,000 deaths in the USA per year due to chronic liver failure or HCC [3]. In addition, HCV dis 25-50% of all liver transplants in US centers, and the ease is responsible for recurrence of HCV infection following liver transplantation is universal [4]. Typically, HCV disease emerges after a 10-20 year period during which symp toms, if they exist at all, are mild and non-specific. Although the prevalence varies greatly among different countries, it has been estimated that up to 170 million people (3% of the world‘s population), are infected with HCV [5]. A recent study in the USA found that 65% of all HCV-infected persons are 30 to 49 years old [6]. | | 出版日期 | Book 2000 | | 关键词 | Androgen; Drogen; cancer; cell; chemistry; drug discovery; drug research; hepatitis; natural product; prevent | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-0348-8385-6 | | isbn_softcover | 978-3-0348-9544-6 | | isbn_ebook | 978-3-0348-8385-6Series ISSN 0071-786X Series E-ISSN 2297-4555 | | issn_series | 0071-786X | | copyright | Springer Basel AG 2000 |
The information of publication is updating
|
|
发表于 2025-3-21 19:37:39
